Facebook
Twitter
LinkedIn
Forward2024 Reflection - W07 - Pharmacy Executives and Leaders - On Demand
This forum is dedicated to driving the progress of pharmacy and revolutionizing healthcare through collaboration, innovation, and the implementation of cutting-edge practices. Attendees will have the opportunity to learn from industry leaders, who will share their triumphs in areas such as medication charge capture, biosimilar adoption, utilization management, split billing, and 340B compliance. These insightful sessions will equip you with valuable insights to enhance pharmacy services within your organization.
Target Audience
- Healthcare Executives
- Healthcare Quality Professionals
- Nurses
- Pharmacists
- Pharmacy Technicians
- Physicians
- Other Healthcare Professionals
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Explain navigating complex healthcare landscapes while driving for success in pharmacy benefit manager (PBM) operations and self-funded plan transformation.
- Discuss strategies to optimize revenue cycle performance to improve financial outcomes for pharmacy services.
- Examine the impact of wholesale acquisition cost (WAC) pricing on the financial sustainability of 340B-covered entities.
- Describe streamlined workflows to implement a preferred product hierarchy to facilitate adoption of biosimilar medications.
FACULTY & PLANNERS
Faculty
Jordan Dow, PharmD, MS, FASHP, FACHE
Vice President and Chief Pharmacy Officer, Assistant Dean, School of Pharmacy
Froedtert & Medical College of Wisconsin
Milwaukee, Wis.
Bree Meinzer, PharmD, BCACP, CACP
Managed Care Manager
University of Toledo Medical Center
Toledo, Ohio
Holly Smith, RPh, MBA
Director of Pharmacy, Ambulatory Services
University of Toledo Medical Center
Toledo, Ohio
Logan Health
Kalispell, Mont.
University of Toledo Medical Center
Toledo, Ohio
John Tollerson, DO
Chief Medical Information Officer
University of Toledo Medical Center
Toledo, Ohio
Priyesh Patel
Vice President and General Manager, Alluma
Vizient
Josephine Lai, PharmD, MBA
Associate Chief Pharmacy Officer
UC Davis Health
Sacramento, Calif.
Chad Hatfield, PharmD, MHA, BCPS
Chief Pharmacy Officer
UC Davis Health
Sacramento, Calif.
Brandy Thompson, CPhT
Pharmacy Revenue Cycle Analyst
UC Davis Health
Sacramento, Calif.
Michael Eagon, PharmD, DPLA
Senior Pharmacy Manager, Ambulatory Pharmacy
The University of Texas Medical Branch
Galveston, Texas
Nathan Vo, RPh, MBA
Senior Pharmacy Manager, Revenue Integrity
The University of Texas Medical Branch
Galveston, Texas
Gaurav Goyal, PharmD, BCPS, BCOP, CPHIMS
Senior Pharmacy Manager, Ambulatory Pharmacy
The University of Texas Medical Branch
Galveston, Texas
Edward Stemley, PharmD, MS
Administrative Director of Pharmacy
The University of Texas Medical Branch
Galveston, Texas
Jim Lichauer
Senior Performance Improvement Program Director, Pharmacy
Vizient
Osama Abdelghany, PharmD, MHA, BCOP
Executive Director, Oncology Pharmacy
Yale New Haven Hospital
Taylor Benoit (Harkness), PharmD, CSP, BCPS, BCACP
Coordinator, Pharmacy Business Strategy
Yale New Haven Hospital
Man Yee Merl, PharmD, BCOP
Manager, Oncology Pharmacy Services
Yale New Haven Hospital
Ryan Stice, PharmD
Chief Pharmacy Officer
Sutter Health
Sacramento, Calif.
Sophia Humphreys, PharmD, MHA, BCBBS
Director, Formulary Management and Clinical Programs
Sutter Health
Sacramento, Calif.
Steven M. Loborec, PharmD, MS, MPH, BCPS
Associate Director of Pharmacy
The Ohio State University Wexner Medical Center
Columbus, Ohio
Julie A. Cowher, MA, RHIA, CHC
Chief Revenue Officer
The Ohio State University Wexner Medical Center
Columbus, Ohio
Michelle Schmitt, MBA, 340B ACE
Vice President, Pharmacy Financial Operations
SSM Health Care
St. Louis, Mo.
Holly Herring, PharmD
Director, 340B Center of Excellence
SSM Health Care
St. Louis, Mo.
Planning Committee
Juli Hermanson, MPH, RDN, CPHQ (Course Director)
Senior Director
Member Education
Vizient, Inc.
Kathy Christensen, BS
VP, Operations
Member Networks
Vizient, Inc.
Katie David, DNP, MS-HSM
Senior Intelligence Director
Member Networks
Vizient, Inc.
Cheryl Jachna, BS
Lead Education Programs Manager
Vizient, Inc.
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director
Continuing Education
Vizient, Inc.
David Levine, MD
Chief Medical Officer
Vizient, Inc.
Lisa McClain, BS
Networks Manager
Member Education
Vizient, Inc.
Mike Oinonen, PharmD, MPH
Vice President
Pharmacy Networks
Vizient, Inc.
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure Statements
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
Steven M. Loborec, PharmD, MS, MPH, BCPS, speaker for this educational activity, is a Stockholder for Pfizer. Inc.
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint Accreditation Statement
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s)
Interprofessional Continuing Education (IPCE)
This activity was planned by, and for, the healthcare team, and learners will receive 3.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Nurses (CNE)
This activity is designated for 3.5 contacts hours.
Pharmacists (CPE)
Vizient, Inc. designates this enduring material for a maximum of 3.5 contact hours for Pharmacists.
Universal Activity Number: JA0006103-0000-24-201-H04-P
Pharmacy Technicians (CPE)
Vizient, Inc. designates this enduring material for a maximum of 3.5 contact hours for Pharmacy Technicians.
Universal Activity Number: JA0006103-0000-24-201-H04-T
Physicians (CME)
Vizient, Inc. designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Healthcare Executives (ACHE)
By attending the Connections Summit offered by Vizient, Inc., participants may earn up to 3.5 ACHE Qualifying Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.
Participants in this program who wish to have it considered for ACHE Qualifying Education hours should list their attendance when they apply to the American College of Healthcare Executives for advancement or recertification. Participants are responsible for maintaining a record of their ACHE Qualifying Education hours. To self-report, participants should log into their MyACHE account and select ACHE Qualifying Education Credit.
Healthcare Quality Professionals (CPHQ)
This activity is approved by NAHQ® for 3.5 CPHQ CE credits.
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 3.50 ACHE
- 3.50 ACPE Pharmacist
- 3.50 ACPE Pharmacy Technician
- 3.50 AMA PRA Category 1 Credit™
- 3.50 ANCC
- 3.50 CPHQ – Certified Professional Healthcare Quality
- 3.50 General CE - Attendance
- 3.50 Interprofessional Continuing Education (IPCE)
Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
Please Note:
- If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
Required Hardware/software
The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.